The worlds fastest growing drugs are already facing Loss of Exclusivity in 2026 Semaglutide is the active ingredient in both Ozempic, an injectable agent for diabetes, as well as Wegovy, an injectable for obesity treatment
This is unlikelyeven for patients with pre-existing conditionsbut is possible in some cases
This includes predictable meals and snacks, flexibility at school or work to accommodate appointments and meal timing, and compassionate communication that reduces shame and blame
You complete our free assessment quiz to determine your eligibility and connect with a licensed healthcare provider who can prescribe a personalized treatment plan if medically appropriate
Carr RD, Larsen MO, Jelic K, Lindgren O, Vikman J, Holst JJ et al